is mounjaro glp 1 drug World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications Women on GLP-1 Drugs More

(PubMed) Ferrante RJ, Andreassen OA, Dedeoglu A, et al

Subcutaneous injection produces rapid peak concentrations within 15-30 minutes followed by relatively quick clearance, potentially favoring daily administration to maintain consistent exposure in acute performance studies

doi: 10.1016/j.intimp.2025.114192

These miRNAs reside in intronic regions within SREBP-1 and 2, the key transcriptional regulators of lipid metabolism 87 , and control the expression of carnitine O -octanoyltransferase (CROT), CPT1A, hydroxyacyl coenzyme A (hydroxyacyl-CoA) dehydrogenase subunit beta (HADHB), and AMPK, targeting their 3 UTR 88